● Recruiting

Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Extended Lymphadenectomy Beyond D2 for Locally Advanced Gastric Cancer (FUGES-30)

Condition: Gastric Cancer · Surgery · Sponsor: Fujian Medical University

PhaseN/A

Planned participants760

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

Taking patients with locally advanced gastric adenocarcinoma (cT2-4a, N-/+, M0) as the research subjects, to evaluate whether the clinical efficacy of laparoscopic beyond D2 regional lymph node dissection for gastric cancer with indocyanine green tracer is better or not.

This description comes directly from the study's public registry record.

Talk to the study team

Mi Lin, phD · 13459152658 · silihuala@qq.com

Hua-Long Zheng, phD · 18359190587 · 291167038@qq.com

Always discuss trial participation with your own doctor first.

Locations (1)

Fujian Medical University Union Hospital

Fuzhou, Fujian, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06945718